Filters

C5ORF44 Antibody

C5ORF44 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameC5ORF44 Primary Polyclonal Antibody
Also known asC5ORF44 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenC5ORF44
SpecificityThis is a highly specific antibody against C5ORF44
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human C5ORF44
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigenC5ORF44
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names CE044_HUMAN, Chromosome 5 open reading frame 44, FLJ13611, FLJ26957, Hypothetical protein LOC80006, MGC48585, UPF0533 protein C5orf44, C5orf44
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetC5ORF44
Short nameC5ORF44 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameC5ORF44 (Antibody to)
Alternative techniqueantibodies
Identity 25828
Gene TRAPPC13
Long gene name trafficking protein particle complex 13
Synonyms gene C5orf44
Synonyms gene name chromosome 5 open reading frame 44
Synonyms FLJ13611 FLJ26957 MGC48585
Synonyms name Trs65-related
Locus 5q12, 3
Discovery year 2008-06-19
Entrez gene record 80006
Pubmed identfication 23394947
RefSeq identity NM_024941
Classification Trafficking protein particle complex
Havana BLAST/BLAT OTTHUMG00000163649

Subscribe to our Newsletter